{"id":182017,"date":"2026-02-14T06:04:13","date_gmt":"2026-02-14T09:04:13","guid":{"rendered":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/"},"modified":"2026-02-14T06:04:13","modified_gmt":"2026-02-14T09:04:13","slug":"los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026","status":"publish","type":"post","link":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/","title":{"rendered":"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div xmlns:default=\"http:\/\/www.w3.org\/2000\/svg\">\t\t<!-- { REGION4 --> <\/p>\n<header class=\"news-headline\">\n<div class=\"news-headline__topics-and-date-wrapper\">    <span class=\"news-headline__publication-date\"> 13 de febrero 2026 &#8211; 13:54<br \/>\n            <\/span><\/div>\n<h2 class=\"news-headline__article-summary\">\t\t<\/h2>\n<p class=\"ignore-parser\">Las cifras de comienzo de 2026 prometen un a\u00f1o pr\u00f3spero para las empresas del gigante asi\u00e1tico.<\/p>\n<\/header>\n<div class=\"detail-highlighted-multimedia content-protected-false\">\n<figure class=\"detail-highlighted-multimedia__figure\">  <img decoding=\"async\" src=\"https:\/\/media.ambito.com\/p\/c2d89aaca5877f89b835ad26f11df62e\/adjuntos\/239\/imagenes\/043\/170\/0043170861\/655x368\/smart\/china-farmaceutica.png\" class=\"detail-highlighted-multimedia__figure-img img-fluid\" alt=\"China lidera en la venta de medicamentos experimental.\" width=\"1024\" height=\"576\" crossorigin=\"anonymous\" fetchpriority=\"high\" decode=\"async\"\/><figcaption class=\"detail-highlighted-multimedia__figcaption\">  <\/figcaption><\/figure>\n<\/p><\/div>\n<article class=\"article-body article-body--first-paragraph content-protected-false\" data-td-script-src=\"https:\/\/www.ambito.com\/td\/modulos\/encuestas\/js\/function-embeds-min-version-1770955623.js\">\n<p>Las <strong>farmac\u00e9uticas mundiales<\/strong> tienen el ojo puesto en la b\u00fasqueda de <strong>medicamentos experimentales<\/strong>, rubro en el cual <strong>China es el pa\u00eds l\u00edder con m\u00faltiples empresas desarroll\u00e1ndolos<\/strong>. En ese sentido, los analistas predicen que los acuerdos de licencia alcanzar\u00e1n un <strong>nuevo r\u00e9cord este a\u00f1o<\/strong>.<\/p>\n<\/article>\n<section class=\"suscription-false printed-edition\" style=\"display:none\">\n<p> El contenido al que quiere acceder es exclusivo para suscriptores.<\/p>\n<p>  <span> <button type=\"button\" name=\"button\" class=\"subscribe-btn mercadopago-btn\">suscribirse<\/button><\/span>  <span class=\"btns\"><button type=\"button\" name=\"button\" class=\"subscribe-btn reload-login\"> ya estoy suscripto<\/button><\/span>  <\/p>\n<\/section>\n<article class=\"article-body article-body--second-paragraph content-protected-false\">\n<p>\u00abEl valor total de estos acuerdos de licencias <strong>va camino de duplicarse nuevamente en los pr\u00f3ximos 18 a 24 meses\u00bb<\/strong>, expres\u00f3 <strong>Tom Barsha<\/strong>, director de fusiones y adquisiciones de Asia Pac\u00edfico en BofA Securities. Seg\u00fan el proveedor de datos Pharmcube, el valor de dichos acuerdos firmados por empresas de la regi\u00f3n de la Gran China \u2014incluye Hong Kong, Macao y Taiw\u00e1n\u2014 <strong>aument\u00f3 casi diez veces el a\u00f1o pasado respecto a 2021, alcanzando una cifra sin precedentes de u$s137.700 millones<\/strong>.<\/p>\n<\/article>\n<section class=\"related-news\">\t\t<span class=\"related-news__title\">Informate m\u00e1s<\/span>\t\t<\/p>\n<div class=\"row row--eq-height\">\n<div class=\"col-12 col-md-6\">\n<article class=\"news-article news-article--landscape-news news-article--landscape-news\">\n<figure class=\"news-article__figure figure\">\n\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/media.ambito.com\/p\/a2e2c2430bb1a049de907b1d30f85959\/adjuntos\/239\/imagenes\/042\/967\/0042967250\/billeteras-virtuales.png\" alt=\"Las billeteras virtuales vuelven a la carga por los sueldos.\u00a0\" title=\"Las billeteras virtuales vuelven a la carga por los sueldos.\u00a0\" width=\"93\" height=\"52\" class=\"news-article__figure-img figure-img img-fluid\"\/>\t\t<\/figure>\n<\/article><\/div>\n<div class=\"col-12 col-md-6\">\n<article class=\"news-article news-article--landscape-news news-article--landscape-news\">\n<figure class=\"news-article__figure figure\">\n\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/media.ambito.com\/p\/59443cc11600cb31db2c1b0cdb661875\/adjuntos\/239\/imagenes\/037\/112\/0037112603\/haciendajpg.jpg\" alt=\"Las tasas del 9% anual a las que podr\u00eda acceder Argentina a los mercados globales no ser\u00edan sustentables.\" title=\"Las tasas del 9% anual a las que podr\u00eda acceder Argentina a los mercados globales no ser\u00edan sustentables.\" width=\"93\" height=\"52\" class=\"news-article__figure-img figure-img img-fluid\"\/>\t\t<\/figure>\n<\/article><\/div>\n<\/div>\n<\/section>\n<article class=\"article-body article-body--third-paragraph content-protected-false\">\n<p>Por otra parte, <strong>Tony Ren<\/strong>, director de investigaci\u00f3n de atenci\u00f3n sanitaria en Asia en Macquarie Capital, predice un <strong>crecimiento m\u00e1s cauteloso de entre 40% y 50%<\/strong> este a\u00f1o, con fuerte crecimiento en los medicamentos considerados como la columna vertebral de los tratamientos oncol\u00f3gicos.<\/p>\n<\/article>\n<article class=\"article-body article-body--fourth-paragraph content-protected-false\">\n<figure id=\"8187672-Libre-1272374137_wrap\" class=\"embed_cont type_imagen\" contenteditable=\"false\">\n<p>china farmaceutica 2 <span onclick=\"parent.parent.TinyMCETdcuerpo.preview_embed('8187672-Libre-1272374137')\" class=\"embed_colapse less\" id=\"8187672-Libre-1272374137_colapse\"\/>  <span onclick=\"parent.parent.TinyMCETdcuerpo.delete_embed('8187672-Libre-1272374137')\" class=\"embed_delete less\" id=\"8187672-Libre-1272374137_delete\"\/><\/p>\n<div id=\"8187672-Libre-1272374137_content\" class=\"embed_content\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/media.ambito.com\/p\/34299b94398c78b1c0ea24430877a9bb\/adjuntos\/239\/imagenes\/043\/170\/0043170860\/730x0\/smart\/china-farmaceutica-2.avif\" alt=\"\" title=\"\" width=\"730\" height=\"383\" id=\"8187672-Libre-1272374137_embed\"\/><\/div><figcaption class=\"embed_wrapper-cont\">   <\/figcaption><\/figure>\n<h2>El 2026 es el a\u00f1o de los medicamentos experimentales<\/h2>\n<p>Para poner en perspectiva, en lo que va del a\u00f1o, <strong>el tama\u00f1o promedio de las transacciones ya alcanz\u00f3 los u$s1.300 millones esta semana, un 76% m\u00e1s que los niveles de 2025 y aproximadamente seis veces el promedio de 2021<\/strong>.<\/p>\n<\/article>\n<article class=\"article-body article-body--fifth-paragraph content-protected-false\">\n<p>Este salto se debe en gran medida a dos grandes acuerdos: el de <strong>AstraZeneca con CSPC Pharmaceutical Group<\/strong> por un medicamento experimental para bajar de peso por un valor de hasta u$s18.500 millones y el acuerdo de licencia de hasta u$s5.600 millones de <strong>AbbVie con RemeGen<\/strong>, abre una nueva pesta\u00f1apara el tratamiento experimental de tumores el mes pasado.<\/p>\n<\/article>\n<article class=\"article-body article-body--remaining-paragraph content-protected-false\">\n<p>En lo que va de <strong>2026<\/strong>, ya se han anunciado<strong> 38 acuerdos de licencia<\/strong>. El a\u00f1o pasado, se firmaron un total de 186 acuerdos de este tipo.<\/p>\n<p>Por otra parte, los honorarios iniciales que las compa\u00f1\u00edas farmac\u00e9uticas globales deben pagar para asegurar los derechos de desarrollo de medicamentos aumentaron a medida que lo hizo la demanda. <strong>La tarifa inicial promedio ascendi\u00f3 a u$s77,7 millones este a\u00f1o, el doble de los u$s38,8 millones en 2025 y aproximadamente tres veces el nivel en 2021<\/strong>.<\/p>\n<h2>La investigaci\u00f3n de mol\u00e9culas, el fuerte de China<\/h2>\n<p>Si bien flaquea en biolog\u00eda, <strong>China encuentra su fuerte en qu\u00edmica <\/strong>y las empresas multinacionales pueden obtener licencias de mol\u00e9culas prometedoras all\u00ed por menos del costo de la I+D interna, seg\u00fan analistas de Macquarie Capital.<\/p>\n<p><strong>China lidera el mundo en tipos de mol\u00e9culas especializadas y representa casi el 90% de toda la actividad global de licencias de conjugados anticuerpo-f\u00e1rmaco (ADC)<\/strong>. Se trata de una clase de medicamentos contra el c\u00e1ncer que administran quimioterapia directamente a las c\u00e9lulas tumorales y al mismo tiempo limitan la exposici\u00f3n al tejido sano.<\/p>\n<\/article>\n<p>\t\t\t\t<!-- REGION4 } -->\n\t\t\t\t\t\t<\/div>\n<p><script>\n!function(f,b,e,v,n,t,s)\n{if(f.fbq)return;n=f.fbq=function(){n.callMethod?\nn.callMethod.apply(n,arguments):n.queue.push(arguments)};\nif(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';\nn.queue=[];t=b.createElement(e);t.async=!0;\nt.src=v;s=b.getElementsByTagName(e)[0];\ns.parentNode.insertBefore(t,s)}(window,document,'script',\n'https:\/\/connect.facebook.net\/en_US\/fbevents.js');\nfbq('init', '2047048335588113');\nfbq('track', 'PageView');\n<\/script><br \/>\n<br \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>13 de febrero 2026 &#8211; 13:54 Las cifras de comienzo de 2026 prometen un a\u00f1o pr\u00f3spero para las empresas del gigante asi\u00e1tico. Las farmac\u00e9uticas mundiales tienen el ojo puesto en la b\u00fasqueda de medicamentos experimentales, rubro en el cual China es el pa\u00eds l\u00edder con m\u00faltiples empresas desarroll\u00e1ndolos. En ese sentido, los analistas predicen que [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":182018,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28],"tags":[],"class_list":["post-182017","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026 - GYS NOTICIAS |<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026 - GYS NOTICIAS |\" \/>\n<meta property=\"og:description\" content=\"13 de febrero 2026 &#8211; 13:54 Las cifras de comienzo de 2026 prometen un a\u00f1o pr\u00f3spero para las empresas del gigante asi\u00e1tico. Las farmac\u00e9uticas mundiales tienen el ojo puesto en la b\u00fasqueda de medicamentos experimentales, rubro en el cual China es el pa\u00eds l\u00edder con m\u00faltiples empresas desarroll\u00e1ndolos. En ese sentido, los analistas predicen que [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"GYS NOTICIAS |\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-14T09:04:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/media.ambito.com\/p\/c2d89aaca5877f89b835ad26f11df62e\/adjuntos\/239\/imagenes\/043\/170\/0043170861\/655x368\/smart\/china-farmaceutica.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/person\/5bedd7ecd35cc35548d89effafa23696\"},\"headline\":\"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026\",\"datePublished\":\"2026-02-14T09:04:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/\"},\"wordCount\":533,\"publisher\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#organization\"},\"image\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png\",\"articleSection\":[\"ECONOMIA\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/\",\"url\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/\",\"name\":\"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026 - GYS NOTICIAS |\",\"isPartOf\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png\",\"datePublished\":\"2026-02-14T09:04:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage\",\"url\":\"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png\",\"contentUrl\":\"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/gysfm.com.ar\/inicio\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#website\",\"url\":\"https:\/\/gysfm.com.ar\/inicio\/\",\"name\":\"GYS NOTICIAS |\",\"description\":\"DIARIO - RADIO ONLINE SAN JUAN ARGENTINA\",\"publisher\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gysfm.com.ar\/inicio\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#organization\",\"name\":\"GYS NOTICIAS |\",\"url\":\"https:\/\/gysfm.com.ar\/inicio\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2023\/07\/LOGOGYS-OK.png\",\"contentUrl\":\"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2023\/07\/LOGOGYS-OK.png\",\"width\":1170,\"height\":872,\"caption\":\"GYS NOTICIAS |\"},\"image\":{\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/person\/5bedd7ecd35cc35548d89effafa23696\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c331d312b5243fb64d5ba28108a447b27c925295129a363082c9ea52c28d32c2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c331d312b5243fb64d5ba28108a447b27c925295129a363082c9ea52c28d32c2?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/gysfm.com.ar\/inicio\"],\"url\":\"https:\/\/gysfm.com.ar\/inicio\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026 - GYS NOTICIAS |","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/","og_locale":"es_ES","og_type":"article","og_title":"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026 - GYS NOTICIAS |","og_description":"13 de febrero 2026 &#8211; 13:54 Las cifras de comienzo de 2026 prometen un a\u00f1o pr\u00f3spero para las empresas del gigante asi\u00e1tico. Las farmac\u00e9uticas mundiales tienen el ojo puesto en la b\u00fasqueda de medicamentos experimentales, rubro en el cual China es el pa\u00eds l\u00edder con m\u00faltiples empresas desarroll\u00e1ndolos. En ese sentido, los analistas predicen que [&hellip;]","og_url":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/","og_site_name":"GYS NOTICIAS |","article_published_time":"2026-02-14T09:04:13+00:00","og_image":[{"url":"https:\/\/media.ambito.com\/p\/c2d89aaca5877f89b835ad26f11df62e\/adjuntos\/239\/imagenes\/043\/170\/0043170861\/655x368\/smart\/china-farmaceutica.png","type":"","width":"","height":""}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#article","isPartOf":{"@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/"},"author":{"name":"admin","@id":"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/person\/5bedd7ecd35cc35548d89effafa23696"},"headline":"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026","datePublished":"2026-02-14T09:04:13+00:00","mainEntityOfPage":{"@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/"},"wordCount":533,"publisher":{"@id":"https:\/\/gysfm.com.ar\/inicio\/#organization"},"image":{"@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png","articleSection":["ECONOMIA"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/","url":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/","name":"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026 - GYS NOTICIAS |","isPartOf":{"@id":"https:\/\/gysfm.com.ar\/inicio\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage"},"image":{"@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png","datePublished":"2026-02-14T09:04:13+00:00","breadcrumb":{"@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#primaryimage","url":"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png","contentUrl":"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2026\/02\/china-farmaceutica.png","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/gysfm.com.ar\/inicio\/los-medicamentos-experimentales-chinos-podian-tener-un-boom-en-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/gysfm.com.ar\/inicio\/"},{"@type":"ListItem","position":2,"name":"Los medicamentos experimentales chinos pod\u00edan tener un boom en 2026"}]},{"@type":"WebSite","@id":"https:\/\/gysfm.com.ar\/inicio\/#website","url":"https:\/\/gysfm.com.ar\/inicio\/","name":"GYS NOTICIAS |","description":"DIARIO - RADIO ONLINE SAN JUAN ARGENTINA","publisher":{"@id":"https:\/\/gysfm.com.ar\/inicio\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gysfm.com.ar\/inicio\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/gysfm.com.ar\/inicio\/#organization","name":"GYS NOTICIAS |","url":"https:\/\/gysfm.com.ar\/inicio\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/logo\/image\/","url":"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2023\/07\/LOGOGYS-OK.png","contentUrl":"https:\/\/gysfm.com.ar\/inicio\/wp-content\/uploads\/2023\/07\/LOGOGYS-OK.png","width":1170,"height":872,"caption":"GYS NOTICIAS |"},"image":{"@id":"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/person\/5bedd7ecd35cc35548d89effafa23696","name":"admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/gysfm.com.ar\/inicio\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c331d312b5243fb64d5ba28108a447b27c925295129a363082c9ea52c28d32c2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c331d312b5243fb64d5ba28108a447b27c925295129a363082c9ea52c28d32c2?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/gysfm.com.ar\/inicio"],"url":"https:\/\/gysfm.com.ar\/inicio\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/posts\/182017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/comments?post=182017"}],"version-history":[{"count":0,"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/posts\/182017\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/media\/182018"}],"wp:attachment":[{"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/media?parent=182017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/categories?post=182017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gysfm.com.ar\/inicio\/wp-json\/wp\/v2\/tags?post=182017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}